Interpretation of Chinese Expert Consensus on the Diagnosis and Management Strategy of Patients with Statin Intoleran-ce:A guiding file for helping to lipid management for Chinese population
Jian-Jun LI
Cardiometabolic Center,National Center for Cardiovascular Disease,Chinese Academy of Medical Science,Fuwai Hos-pital,Beijing,China
摘要：It is well-known that elevated low-density lipoprotein cholesterol(LDL-C)is a causal risk factor for atheroscler-otic cardiovascular disease(ASCVD),statins are cornerstone drugs for the cause-based treatment of ASCVD,which has created a new era for ASCVD therapy.However,statin intolerance is not clinically uncommon,which there are several issues with confu-sion and misunderstandings.Hence,a file named Chinese Expert Consensus on the Diagnosis and Management Strategy of Pa-tients With Statin Intolerance,like a navigator,has recently been published written by a team of experts from the Cardiovascular Metabolic Medicine Professional Committee,Expert Committee of the National Center for Cardiovascular Diseases aiming to en-hance the standardized clinical application of statins and improve the prevention and clinical outcome.In this article,author briefly summarized the key points of above consensus in order to helping to comprehending the content of the consensus sugges-tions.
机标关键词：interpretationmanagementconsensuschinesepopulationstrategyexpertwith
论文发表日期：2024-07-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：3( 713-715 )